United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as ...

Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.